References
1. Barnes PJ. Inflammatory endotypes in COPD. Allergy.2019;74:1249-1256.
2. Jacquet A, Robinson C. Proteolytic, lipidergic and polysaccharide
molecular recognition shape innate responses to house dust mite
allergens. Allergy. 2020;75:33-53.
3. Machado MN, Mazzoli-Rocha F, Casquilho NV, et al. Bone Marrow-Derived
Mononuclear Cell Therapy in Papain-Induced Experimental Pulmonary
Emphysema. Front Physiol. 2018;9:121.
4. Wright JL, Cosio M, Churg A. Animal models of chronic obstructive
pulmonary disease. Am J Physiol Lung Cell Mol Physiol.2008;295:L1-L15.
5. McDowell PJ, Heaney LG. Different endotypes and phenotypes drive the
heterogeneity in severe asthma. Allergy. 2020;75:302-310.
6. Iwamoto H, Gao J, Koskela J, et al. Differences in plasma and sputum
biomarkers between COPD and COPD-asthma overlap. Eur Respir J.2014;43:421-429.
7. Akbarshahi H, Menzel M, Ramu S, Mahmutovic Persson I, Bjermer L,
Uller L. House dust mite impairs antiviral response in asthma
exacerbation models through its effects on TLR3. Allergy.2018;73:1053-1063.
8. Cowland JB, Borregaard N. Molecular characterization and pattern of
tissue expression of the gene for neutrophil gelatinase-associated
lipocalin from humans. Genomics. 1997;45:17-23.
9. Melen E, Guerra S, Hallberg J, Jarvis D, Stanojevic S. Linking COPD
epidemiology with pediatric asthma care: Implications for the patient
and the physician. Pediatr Allergy Immunol. 2019;30:589-597.